AAAAAA

   
Results: 1-7 |
Results: 7
A randomized trial of interferon-alpha in cervical dysplasia
Authors: Gostout, BS Hartmann, LC Suman, VJ Fay, NE Jefferies, JA Morton, RF Gaffey, TA Farr, GH Tschetter, LK Abu-Ghazaleh, S Gallenberg, MM Hatfield, AK
Citation: Bs. Gostout et al., A randomized trial of interferon-alpha in cervical dysplasia, INT J GYN O, 74(2), 2001, pp. 207-210
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma
Authors: Buckner, JC Schomberg, PJ McGinnis, WL Cascino, TL Scheithauer, BW O'Fallon, JR Morton, RF Kuross, SA Mailliard, JA Hatfield, AK Cole, JT Steen, PD Bernath, AM
Citation: Jc. Buckner et al., A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma, CANCER, 92(2), 2001, pp. 420-433
A randomized phase II and pharmacokinetic study of dacarbazine in patientswith recurrent glioma
Authors: Rajkumar, SV Reid, JM Novotny, PJ Safgren, SL Scheithauer, BW Johnson, PS Nair, S Morton, RF Hatfield, AK Krook, JE Ames, MM Buckner, JC
Citation: Sv. Rajkumar et al., A randomized phase II and pharmacokinetic study of dacarbazine in patientswith recurrent glioma, J NEURO-ONC, 49(3), 2000, pp. 255-261
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas
Authors: Galanis, E Buckner, JC Novotny, P Morton, RF McGinnis, WL Dinapoli, R Schomberg, P O'Fallon, JR
Citation: E. Galanis et al., Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas, J NEUROSURG, 93(2), 2000, pp. 201-207
Phase II North Central Cancer Treatment Group study of 2-chlorodeoxyadenosine in patients with recurrent glioma
Authors: Rajkumar, SV Burch, PA Nair, S Dinapoli, RP Scheithauer, B O'Fallon, JR Etzell, PS Leitch, JM Morton, RF Marks, RS
Citation: Sv. Rajkumar et al., Phase II North Central Cancer Treatment Group study of 2-chlorodeoxyadenosine in patients with recurrent glioma, AM J CL ONC, 22(2), 1999, pp. 168-171
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer
Authors: Marschke, RF Grill, JP Sloan, JA Wender, DB Levitt, R Mailliard, JA Gerstner, JB Ghosh, C Morton, RF Jett, JR
Citation: Rf. Marschke et al., Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer, AM J CL ONC, 22(1), 1999, pp. 15-17
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression
Authors: Perry, A Jenkins, RB O'Fallon, JR Schaefer, PL Kimmel, DW Mahoney, MR Scheithauer, BW Smith, SM Hill, EM Sebo, TJ Levitt, R Krook, J Tschetter, LK Morton, RF Buckner, JC
Citation: A. Perry et al., Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression, CANCER, 86(4), 1999, pp. 672-683
Risultati: 1-7 |